ANRO

Alto Neuroscienc

25.16

+3.29+15.04%

After Hours: 25.03 -0.13 -0.52%19:30 11/06 EST

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE22.12/21.87

TODAY RANGE21.87-25.45

VOL617.54K

MARKET CAP987.33M

52 WEEK RANGE10.20-37.48

AVG VOL (3M)571.18K

% TURNOVER1.57%

TURNOVER--

P/E (TTM)-10.3123

% RANGE15.82%

EPS(TTM)-2.4398

P/E(FORWARD)-9.0327

P/B4.027

BVPS6.25

DIVIDEND--

P/S--

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP898.76M

SHARES OUTSTANDING39.24M

NEXT EARNINGS--

FREE FLOAT35.72M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

TipRanks·10/19 13:35
Alto Neuroscience price target raised to $60 from $55 at H.C. Wainwright
Seeking Alpha·10/15 17:07
Alto Neuroscience: Doubts Around Depression Candidate Merit Downgrade To Hold
TipRanks·10/02 20:50
Analysts Are Bullish on Top Healthcare Stocks: Alto Neuroscience, Inc. (ANRO), Phreesia (PHR)
TipRanks·09/23 08:40
Alto Neuroscience (ANRO) Defendants Move to Dismiss Third Amended Securities Complaint Over Phase 2b Trial Disclosures
Seeking Alpha·09/17 14:20
10 small-cap healthcare stocks with the strongest momentum grades
Seeking Alpha·08/28 14:14
Alto Neuroscience promotes Nick Smith to president & CFO
TipRanks·08/27 22:30
Alto Neuroscience Promotes Smith to President, CFO
TipRanks·08/27 20:15
Alto Neuroscience names Nick Smith president, CFO
Dow Jones·08/27 20:05
*Alto Neuroscience Promotes Nick Smith To President And Chief Financial Officer >ANRO
TipRanks·08/21 19:36
Alto Neuroscience Lawsuit Dismissed for Now, With Investors Given Chance to Amend Claims
Dow Jones·08/17 16:21
Alto Neuroscience Price Target Raised to $55.00/Share From $50.00 by HC Wainwright & Co.
Dow Jones·08/17 16:21
Alto Neuroscience Is Maintained at Buy by HC Wainwright & Co.
TipRanks·08/17 15:30
Alto Neuroscience price target raised to $55 from $50 at H.C. Wainwright
TipRanks·08/17 08:53
Alto Neuroscience reports Q EPS (65c), consensus (77c)

Same Industry

Name/Symbol

Change%

Price

REGN

GRDX

BNTX

UTHR

VRTX

SIGA

Moderna

MRNA

+5.27%

254.19

CRL

MEDP

TLPH

ICLR

CBPO

IQV

MOLN

ARCT

GILD

PRAH

INCY

APVO

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.